Physician profile
Janice Rodriguez Hernandez
NPI 1104266006
$159,863.71
in general payments reported to CMS, 2019-2025
9 companies · $52K in 2025
The $52K reported for 2025 was more than what 98% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $103 · 2021: $87.50 · 2022: $7,561 · 2023: $30K · 2024: $71K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125K · Travel and Lodging: $17K · Consulting Fee: $5,670 · Food and Beverage: $4,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124,589.00 |
| Travel and Lodging | $17,316.16 |
| Consulting Fee | $5,670.00 |
| Food and Beverage | $4,381.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $144,582.09 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $7,566.86 | 2024-2025 | Daybue |
| Ucb, INC. | $7,152.29 | 2019-2025 | Fintepla |
| Neurelis, INC. | $232.37 | 2023-2025 | Valtoco |
| Biomarin Pharmaceutical INC. | $103.30 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $100.11 | 2024 | |
| Ptc Therapeutics, INC. | $78.52 | 2024 | Emflaza |
| Chiesi USA, INC. | $28.16 | 2019 | |
| Sobi, INC | $20.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Rodriguez Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.